The prevalent predicament of relapsed acute myeloid leukemia.
about
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid LeukemiaIsolated granulocytic sarcoma of the nasopharynx: a case report and review of the literature.Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndromeThioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxideTelomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy.Effects of down-regulation of clusterin by small interference RNA on human acute myeloid leukemia cells.Antitumoral effect of Ocoxin on acute myeloid leukemia.Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia CellsMolecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape.Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaAssessing utility values for treatment-related health states of acute myeloid leukemia in the United States
P2860
Q28084813-18622EEA-0DAD-422C-860A-064F72518B1BQ30445482-C53EC3D9-4151-45F8-B1F7-B1AB2CE789A4Q33865044-2ADF8BA2-E8DD-4ACC-94E0-4D8B503D4176Q34121354-5FC3D30D-468D-4379-8B0D-217CE94C9655Q35049985-D16AE50E-5647-49DB-8D6C-9BD122B6A20AQ36492908-3972496D-A513-4AE6-97DA-905385FE2EAFQ36905886-3882EF77-44D2-45DB-BBDC-E2D632D03663Q37712493-A24BE05C-8F02-4AA9-85A3-8EF30DE0DF15Q38755213-D8F3338C-7103-4CFF-B94B-A7A7D2FA1670Q39342733-1062D279-A885-4BEF-9292-A9DF434A1684Q41643520-8C8C12CA-EB43-4820-8311-FE7191E9B3ECQ57492451-6192C493-C57D-476E-B358-9FEF4A472F95Q58706473-2F78A29C-F255-479B-8737-74EEFF758DA3
P2860
The prevalent predicament of relapsed acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The prevalent predicament of relapsed acute myeloid leukemia.
@en
type
label
The prevalent predicament of relapsed acute myeloid leukemia.
@en
prefLabel
The prevalent predicament of relapsed acute myeloid leukemia.
@en
P1476
The prevalent predicament of relapsed acute myeloid leukemia.
@en
P2093
Jeffrey Szer
P356
10.1182/ASHEDUCATION-2012.1.43
P577
2012-01-01T00:00:00Z